POM SEC Filings: 8-K, 10-Q, S-3 & 424B – Pomdoctor

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 14, 2026

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Apr 30, 2026

News

TYPE

HEADLINE

FILED AT

6-K

POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement

Nov 6, 2026

6-K

Pomdoctor Limited Enters Into Debt Conversion Agreement to Issue Class A Ordinary Shares to Satisfy Indebtedness

Nov 4, 2026

6-K

POMDOCTOR LIMITED Receives Nasdaq Deficiency Notifications Regarding Market Value and Publicly Held Shares Requirements

Nov 2, 2026

6-K

POMdoctor Limited Announces Termination of ADR Program, Share Consolidation, and Direct Nasdaq Listing of Class A Ordinary Shares

Oct 19, 2026

6-K

POMDOCTOR LIMITED Receives Nasdaq Staff Delisting Determination Regarding Minimum Bid Price

Oct 9, 2026

6-K

Pomdoctor Limited Announces Results of Extraordinary General Meeting of Shareholders

Oct 2, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

SHARE RESALE REGISTRATION | Shares amount: 5,000,004 | Share price: $4

Oct 9, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 28, 2026

F-6 POS

Form F-6 POS - Post-effective amendments for immediately effective filing

May 28, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 5, 2025

F-1/A

SHARE RESALE REGISTRATION

Sep 26, 2025

F-1/A

SHARE RESALE REGISTRATION | Shares amount: 5,000,004 | Share price: $5

Sep 19, 2025

F-6/A

Form F-6/A - Registration of American Depository Receipt shares, not immediately effective: [Amend]

Sep 10, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Bao Wenqing (Reporting)

Apr 30, 2026

Li Daxue Donnelly (Reporting)

Apr 16, 2026

Jing Yuanyuan Crystal (Reporting)

Apr 3, 2026

Xu Li jinfuhua (Reporting)

Apr 3, 2026

Wei Dexiang (Reporting)

Mar 31, 2026

Luo Guoji (Reporting)

Mar 31, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 1, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 1, 2025

CORRESP

Form CORRESP - Correspondence

Sep 26, 2025

CORRESP

Form CORRESP - Correspondence

Sep 26, 2025

CORRESP

Form CORRESP - Correspondence

Aug 5, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jul 24, 2025

Pomdoctor Limited POM · SEC Filings